Suven Life Sciences Ltd share price logo

Suven Share Price

(SUVEN)

₹117.6▲0.72%

as on 04:02PM, 21 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Suven Performance

  • Day's Low

    Day's High

    ₹116.63
    Day's Price Range
    ₹121

  • 52 Week's Low

    52 Week's High

    ₹82.95
    52-Week Price Range
    ₹169.3
1 Month Return-9.07 %
3 Month Return+ 0.3 %
1 Year Return+ 11.22 %
Previous Close₹118.45
Open₹118.45
Volume2.45L
Upper Circuit-
Lower Circuit-
Market Cap₹2,583.08Cr

Suven Key Statistics

P/E Ratio

-18.03

PEG Ratio

10.02

Market Cap

₹2,583.08 Cr

P/B Ratio

2.57

EPS

-4.82

Dividend Yield

0

Sector

Healthcare

ROE

-2.36

Suven Mutual Fund Holdings

Key events for Suven Life Sciences Ltd

  • Suven Life Sciences Reports Decline in Net Sales - 28 Jan, 2025

    Suven Life Sciences reported a 34.31% decline in net sales to Rs 1.61 crore for December 2024. The company also faced a quarterly net loss of Rs 39.12 crore, with EBITDA remaining negative at Rs 37.58 crore. Shares closed at Rs 116.02, reflecting a -17.46% return over the last six months.

  • Suven Life Sciences Reports Decline in Sales and Losses - 27 Jan, 2025

    Suven Life Sciences reported a 34.31% decline in net sales to Rs 1.61 crore for December 2024, with a net loss of Rs 13.27 crore. EBITDA also turned negative at Rs 11.73 crore. The stock has seen a -9.73% return over the last six months.

  • Suven Life Sciences Shares Surge on Trial Progress - 08 Jan, 2025

    Suven Life Sciences shares rose significantly after the company announced the dosing of first subjects in a Phase-1 clinical trial for SUVN-I6107, a drug targeting cognitive disorders. The stock closed 10.27% higher, reflecting positive investor sentiment following the FDA-approved trial update.

Insights on Suven Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SUVEN stock has moved up by 2.0%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -49.64 Cr → -39.12 Cr (in ₹), with an average increase of 26.9% per quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 28.34% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.34% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.27% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.2% return, outperforming this stock by 86.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 63.8% return, outperforming this stock by 52.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 6.61 Cr → 3.24 Cr (in ₹), with an average decrease of 51.0% per quarter

Suven Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹2.45Cr (-)₹2.39Cr (↓2.45%)₹1.01Cr (↓57.74%)₹2.57Cr (↑154.46%)₹1.61Cr (↓37.35%)
Net Income-₹41.76Cr (-)-₹26.54Cr (↓36.45%)-₹28.04Cr (↑5.65%)-₹49.64Cr (↑77.03%)-₹39.12Cr (↓21.19%)
Net Profit Margin-1,704.49% (-)-1,110.46% (↓34.85%)-2,776.24% (↑150.01%)-1,931.52% (↓30.43%)-2,429.81% (↑25.80%)
Value in ₹ crore
Details2021202220232024
Total Assets₹415.38Cr (-)₹486.35Cr (↑17.09%)₹860.44Cr (↑76.92%)₹851.48Cr (↓1.04%)
Total Liabilities₹13.72Cr (-)₹10.37Cr (↓24.42%)₹6.99Cr (↓32.59%)₹6.10Cr (↓12.73%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹45.15Cr (-)-₹36.68Cr (↓18.76%)-₹36.62Cr (↓0.16%)-₹22.92Cr (↓37.41%)-₹20.56Cr (↓10.30%)

Index Inclusions

BSE Healthcare

₹39,619.96

-1.6 (▲-643.73%)

BSE Small-Cap

₹45,856.00

-0.43 (▲-198.94%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Suven Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
70.27%
0.00
Foreign Institutions
0.34%
-0.06
Mutual Funds
1.05%
0.03
Retail Investors
28.34%
0.00
Others
0%
-66.67

Suven Key Indicators

Details20202021202220232024
Earning Per Share (₹)-6.82-5.22-7.73-5.42-4.82
Details20202021202220232024
Return On Equity %-3.48-5.73-9.17-4.2-2.36
Details20202021202220232024
Return On Assets %-22.94-17.37-25.08-13.75-12.34
Details20202021202220232024
Book Value Per Share (₹)10.385.146.0917.2112.38

Suven Valuation

Suven in the last 5 years

  • Overview

  • Trends

Lowest (-165.11x)

February 27, 2020

Today (-18.03x)

February 20, 2025

Industry (93.53x)

February 20, 2025

Highest (-6.67x)

March 27, 2023

LowHigh

Suven Earnings and Dividends

  • Suven Life Sciences Ltd Earnings Results

    Suven Life Sciences Ltd’s net profit jumped 6.32% since last year same period to ₹-39.12Cr in the Q3 2024-2025. On a quarterly growth basis, Suven Life Sciences Ltd has generated 21.19% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Suven Life Sciences Ltd Dividends February,2019

    In the quarter ending December 2018, Suven Life Sciences Ltd has declared dividend of ₹1.50 - translating a dividend yield of 1.27%.

    Read More about Dividends

Suven Technicals Summary

Bearish

Neutral

Bullish

Bearish

Suven Life Sciences Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

Suven Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Suven Life Sciences Ltd
Suven Life Sciences Ltd
NA₹2,583.08 Cr22.04%0.50-₹106 Cr₹11 Cr
Metropolis Healthcare Ltd
Metropolis Healthcare Ltd
BUY₹8,605.49 Cr-1.16%0.58₹128 Cr₹1,207 Cr
Nidan Laboratories & Healthcare Ltd
Nidan Laboratories & Healthcare Ltd
NA₹32.32 Cr-16.05%0.58NANA
Aashka Hospitals Ltd
Aashka Hospitals Ltd
NA₹242.89 Cr-1.96%0.59NANA
Maestros Electronics & Telecommun. Systems Ltd
Maestros Electronics & Telecommun. Systems Ltd
NA₹99.63 Cr40.27%0.58NANA
See all

About Suven

Suven Life Sciences Limited (erstwhile Suven Pharmaceuticals), established in 1989, is in the business of Contract Research and Manufacturing Services (CRAMS), providing process research and rapid response pilots scale 16 manufacture, custom synthesis, process R&D, and contract manufacturing of intermediates, APIs and formulations. It has two international wholly owned subsidiaries and one Indian wholly owned subsidiary. With the aim of expanding its drug discovery portfolio, a remarkable growth of 71% in total sales and a 325% growth in profit after tax (PAT) was registered during 2000-01. In addition, the company also acquired a pilot plant and got its recertification of ISO 9002 during the same year. In 2013-14, Suven granted an exclusive license to Taro Pharmaceuticals to market its product Head Lice Lotion in the US, Canada and Mexico, estimated at US$35million. During FY2014-15, one of its lead clinical candidates SUVN 502 has successfully completed the Phase 1b clinical trial, leading way for the entry into Proof of Concept (PoC) Phase 2a study. Thesaid year also saw the Company issuing and alloting 10, 453, 690 equity shares of Re 1/ each at a premium of Rs190.32 per share by way of QIP issue. In 2018-19, a Scheme of Arrangement for Demerger was initiated between Suven Life Sciences and Suven Pharmaceuticals Limited, resulting in a mirror shareholding of Suven Life Sciences in Suven Pharmaceuticals Limited. Consequently, Suven Pharmaceuticals Ltd., India and Suven Pharma Inc., USA became subsidiary companies of the group. As of 31st March 2019, investments were made to Suven Neurosciences Inc., a wholly owned subsidiary, amounting to Rs. 13, 636 lakh and no investments were made into newly formed Suven Pharma Inc., USA.

Share Price: ₹117.60 per share as on 21 Feb, 2025 04:02 PM
Market Capitalisation: ₹2,583.08Cr as of today
Revenue: ₹1.61Cr as on December 2024 (Q4 24)
Net Profit: ₹-39.12Cr as on December 2024 (Q4 24)
Listing date: 23 Oct, 2003
Chairperson Name: Venkateswarlu Jasti
OrganisationSuven
HeadquartersHyderabad
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Suven Life Sciences Ltd

What is Suven Life Sciences Ltd price today?

Suven Life Sciences Ltd share price today stands at ₹117.6, Open: ₹118.45, Previous Close: ₹118.45, High: ₹121, Low: ₹116.63, 52 Week High: ₹169.3, 52 Week Low: ₹82.95.

How to Buy Suven Life Sciences Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Suven Life Sciences Ltd shares

Is Suven Life Sciences Ltd listed on NSE?

Suven Life Sciences Ltd is listed on NSE

Is Suven Life Sciences Ltd listed on BSE?

Suven Life Sciences Ltd is listed on BSE

What are today's High and Low prices of Suven Life Sciences Ltd?

  • Today's highest price of Suven Life Sciences Ltd is ₹121.
  • Today's lowest price of Suven Life Sciences Ltd is ₹116.63.

What are today's traded volumes of Suven Life Sciences Ltd?

Today's traded volume of Suven Life Sciences Ltd(SUVEN) is 2.45L.

What is today's market capitalisation of Suven Life Sciences Ltd?

Today's market capitalisation of Suven Life Sciences Ltd(SUVEN) is ₹2583.08Cr.

What is the 52 Week High and Low Range of Suven Life Sciences Ltd?

Suven Life Sciences Ltd (SUVEN)
Price
52 Week High
₹169.3
52 Week Low
₹82.95

How much percentage Suven Life Sciences Ltd is down from its 52 Week High?

Suven Life Sciences Ltd (SUVEN) share price is ₹117.6. It is down -30.54% from its 52 Week High price of ₹169.3

How much percentage Suven Life Sciences Ltd is up from its 52 Week low?

Suven Life Sciences Ltd (SUVEN) share price is ₹117.6. It is up 41.77% from its 52 Week Low price of ₹82.95

What are the historical returns of Suven Life Sciences Ltd?

Suven Life Sciences Ltd (SUVEN)
Returns
1 Day Returns
-0.85%
1 Month Returns
-9.07%
3 Month Returns
0.3%
1 Year Returns
11.22%

What is the PE ratio of Suven Life Sciences Ltd today?

PE Ratio of Suven Life Sciences Ltd is -18.03

PE ratio = Suven Life Sciences Ltd Market price per share / Suven Life Sciences Ltd Earnings per share